Seeking Alpha

Johnson & Johnson (JNJ)

()

News & PR
Market Currents

Buzz
Twitter: JNJ

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

J&J's Ethicon Acquires Acclarent for $785 Million

Dec 18 • Zacks.com • Comment!
The Dividend Aristocrats of 2010

Dec 16 • Dividends4Life • 1 Comment
Creating an Inflation-Proof Source of Income in Retirement

Dec 16 • Dividend Growth Investor • 14 Comments
Large Caps Are Breaking Out: Is This a Trend?

Dec 14 • TraderMark • 4 Comments
2010's Dividend Aristocrats

Dec 14 • David I. Templeton • 4 Comments
Dividend Growth in Emerging Economies

Dec 11 • Dividend Tree • 6 Comments
High Hopes Remain for Celgene's Revlimid

Dec 9 • EP Vantage • 2 Comments
Dividend Investing: When to Break Your Rules

Dec 9 • Dividend Growth Investor • 9 Comments
17 Stocks for the Three Major Categories of Dividend Investing

Dec 9 • Dividends4Life • 27 Comments
3M Sees Increased Organic Sales Volumes for 2010

Dec 9 • Tom Armistead • Comment!
Change in the Tone of the Markets

Dec 8 • Jeffrey Saut • 8 Comments
The Principles of Dividend Investing

Dec 7 • Chuck Carnevale • 6 Comments
Global Pharmaceutical Industry Boosted by Rising Drug Approvals and Sales in Q3

Dec 7 • Research Recap • Comment!
Opportunities in Dividend Investing: A Seeking Alpha Expert Panel

Dec 6 • SA Editors • 9 Comments
9 Small Cap and Mid Cap Dividend Raisers

Dec 3 • Dividends4Life • 10 Comments
Top Dividend Stocks to Accumulate Now

Dec 2 • Dividend Growth Investor • 32 Comments
The 10 Most Valuable U.S. Companies vs. Treasury Yields

Dec 2 • YCHARTS.com • 12 Comments
Is It Time for Capital Preservation Mode?

Dec 2 • Peter Mycroft Psaras • 16 Comments
Celgene: New Studies Expected to Boost Sales

Nov 30 • Ockham Research • 2 Comments
Health Care Takes Bigger Slice of Risk Capital

Nov 30 • Sydney Williams • Comment!
3 Stocks that Could Pay Out Larger Dividends

Nov 29 • Mark Riddix • 24 Comments
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
Theravance, Inc.: Wait to Buy on Dip

Nov 26 • Penn Bioinvestor • 4 Comments
Berkshire Hathaway Stock Portfolio: At Risk of Resembling an Index Fund?

Nov 24 • Jacob Wolinsky • 22 Comments
When CDS Spreads and Equity Prices Rise in Tandem

Nov 24 • Jim Delaney • 1 Comment
Saut: Expect More Upside, Driven by Underinvested Institutional Investors

Nov 24 • Jeffrey Saut • 6 Comments
J&J vs. 10-Year T-Bonds: The Power of Rising Dividends

Nov 19 • Rising Dividend Investing • 23 Comments
Most and Least Heavily Shorted Russell 1,000 Stocks

Nov 18 • Bespoke Investment Group • 2 Comments
Winning Investment Strategy: Focus on Value-Based Dividend Growth

Nov 18 • Dividends4Life • 5 Comments
What Are Your Dividend Investment Goals?

Nov 18 • Dividend Growth Investor • 12 Comments
Analyze Earnings Yield Like Warren Buffett

Nov 17 • YCHARTS.com • 1 Comment
Dogs of the Dow: How Do They Look Today?

Nov 15 • Larry Bellehumeur • 3 Comments
14 Promising Chinese Dividend Stocks

Nov 15 • Hao Jin • 12 Comments
7 Dividend Stocks to Prove Buy-and-Hold Isn't Dead

Nov 11 • Dividends4Life • 42 Comments
Where Are the Original Dividend Aristocrats Now?

Nov 11 • Dividend Growth Investor • 10 Comments
Why I'm Still Buying Johnson & Johnson at These Levels

Nov 10 • Dividends4Life • 12 Comments
U.S. Healthcare Legislation Investment Impact

Nov 9 • Richard Shaw • 20 Comments
The Reluctant Bull: My Portfolio

Nov 8 • Old Trader • 28 Comments
Quality Individual U.S. Companies: The Short List

Nov 8 • Richard Shaw • 1 Comment
Estimating Future Dividend Growth

Nov 6 • Dividend Growth Investor • 8 Comments
How Are the S&P's Dividend Aristocrats Performing?

Nov 5 • David I. Templeton • 8 Comments

Johnson & Johnson (JNJ)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers